Mifepristone, also sold under the brand name Mifeprex, is approved by the FDA to end a pregnancy up to 10 weeks.
The single tablet works by blocking the hormone progesterone and is typically paired with a second drug, misoprostol, which causes cramping to empty the uterus. Only mifepristone though is subject to a special regulatory framework used by the FDA to minimize the risks of certain drugs.The FDA did not issue a formal statement Tuesday, but updated information about the drug online.
Still, she said, the FDA action signals an intention by the federal government to treat the drug more like other medications. Opponents of abortion rights say a top priority this year is challenging FDA's approval of the drug in court and trying to convince the government to crack down on unregulated sites selling the pill online. In one closely watched case in a federal court in Texas, the Alliance for Defending Freedom argued the FDA overstepped its authority in greenlighting the drug more than two decades ago.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA will greenlight pharmacies to fill prescriptions for abortion pill, agency saysThe FDA is relaxing the rules on the abortion pill mifepristone, saying pharmacies can now fill prescriptions for the drug so long as they become certified to do so.
Consulte Mais informação »
House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugA congressional investigation into the FDA's review process for an Alzheimer's treatment found that the agency 'deviated' from its standard procedures to approve the Aduhelm drug with inconsistent data.
Consulte Mais informação »
FDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Consulte Mais informação »
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Consulte Mais informação »
Sesame joins the major food allergens list, FDA saysSesame has joined the list of major food allergens defined by law, according to the U.S. Food and Drug Administration.
Consulte Mais informação »
Evaxion's stock soars after getting FDA approval for mid-stage cancer trialU.S.-listed shares of Evaxion Biotech A/S undefined jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration...
Consulte Mais informação »